🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsCardiovascular OutcomesHas anyone dealt with glp-1 and peripheral arterial disease?

Has anyone dealt with glp-1 and peripheral arterial disease?

traveltech_sara Fri, Jan 31, 2025 at 6:48 PM 24 replies 2,011 viewsPage 1 of 5
This thread is more than 16 months old. Information may be outdated. Consider searching for more recent discussions.
traveltech_sara
Member
156
678
Jan 2025
Remote, USA
Jan 31, 2025 at 6:48 PM#1

My reason for being on this is cardiovascular rather than cosmetic, which puts me in a small minority in most of these threads.

The question I want answered is how much of the SELECT benefit is plausibly independent of the weight loss, and whether that distinction changes anything practical.

Tell me what I have not thought of.

21 24MeganSA_TX, LarryQC_SD, wanda_boise and 18 others
Reply Quote Save Share Report
Dr.SleepRoch
Senior Member
1,123
5,678
Apr 2024
Rochester, MN
Jan 31, 2025 at 7:03 PM#2
traveltech_sara said:
My reason for being on this is cardiovascular rather than cosmetic, which puts me in a small minority in most of these threads.

Positive "side effect" of cardiovascular risk: my blood pressure dropped so much that I'm now off losartan entirely! My cardiologist is thrilled.

If you're on BP meds and losing weight on a GLP-1, monitor your BP at home regularly. Hypotension symptoms (dizziness, lightheadedness when standing) mean your BP meds may need reduction. Don't wait for your next scheduled appointment — call your doctor.

22 0kim_atl_prep, sarah_TO, wendy_avl and 19 others
Reply Quote Save Share Report
bri_stats
Member
789
3,456
May 2024
Seattle, WA
Jan 31, 2025 at 7:18 PM#3
Dr.SleepRoch said:
Positive "side effect" of cardiovascular risk: my blood pressure dropped so much that I'm now off losartan entirely!

I'm 58 years old and want to share my perspective on cardiovascular risk as an older member of this community.

My doctor was initially hesitant because of my age, but the SELECT trial included patients up to 72 and showed consistent benefit across age groups. We started at the lowest dose with closer monitoring.

11 months later: down 58 lbs, off atorvastatin, A1C from 7.6% to 5.3%. My cardiologist is thrilled. cardiovascular risk is absolutely relevant for older adults — don't let anyone tell you otherwise.

23 1TomFromTexas, mike.trainer_LA, sarah_nash92 and 20 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
roxy_nash
Member
178
890
Dec 2024
Nashville, TN
Jan 31, 2025 at 7:33 PM#4
traveltech_sara said:
My reason for being on this is cardiovascular rather than cosmetic, which puts me in a small minority in most of these threads.

Second this. I had assumed I was the exception until I read this.

Last edited: Feb 1, 2025 at 1:33 AM
24 2Dr.NephBHM_UK, kim_atl_prep, sarah_TO and 21 others
Reply Quote Save Share Report
Dr.SurgeonPGH
Senior Member
1,345
6,789
Mar 2024
Pittsburgh, PA
Jan 31, 2025 at 8:53 PM#5

Adding the clinical framing, because it changes how the question reads.

CRP reduction on cardiovascular risk — this is the lab result that excites me most:

Baseline hsCRP: 7.0 mg/L (high cardiovascular risk)
Month 6 hsCRP: 2.5 mg/L (moderate risk)
Month 12 hsCRP: 0.6 mg/L (low risk)

This level of inflammatory marker reduction is comparable to what you'd see with statin therapy. Combined with the weight loss, my 10-year ASCVD risk score dropped from 14% to 5%. My cardiologist is genuinely impressed.

25 3B12Beth, RickReta_CO, PharmHunterJen and 22 others
Reply Quote Save Share Report
1235

Similar Threads

SELECT trial: 20% MACE reduction — mechanistic deep dive7 replies
Semaglutide cardiovascular benefit independent of weight loss11 replies
STEP-HFpEF: semaglutide in heart failure with preserved EF15 replies
GLP-1 and arterial inflammation — hsCRP and IL-6 reduction data18 replies
Lp(a) on GLP-1 agonists — any impact on this risk factor?8 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register